T. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau-young, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1066, issue.1, pp.29-36, 1991.
DOI : 10.1016/0005-2736(91)90246-5

M. Althuis, J. Dozier, W. Anderson, S. Devesa, and L. Brinton, Global trends in breast cancer incidence and mortality 1973-1997, International Journal of Epidemiology, vol.34, issue.2, pp.405-412, 2005.
DOI : 10.1093/ije/dyh414

K. Anwer, C. Meaney, G. Kao, N. Hussain, R. Shelvin et al., Cationic lipid-based delivery system for systemic cancer gene therapy, Cancer Gene Therapy, vol.7, issue.8, pp.1156-1164, 2000.
DOI : 10.1038/sj.cgt.7700218

J. Armstrong, G. Hempel, S. Koling, L. Chan, T. Fisher et al., Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients, Cancer, vol.102, issue.1, pp.103-111, 2007.
DOI : 10.1002/cncr.22739

S. Arpicco, S. Canevari, M. Ceruti, E. Galmozzi, R. F. Cattel et al., Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids, Il Farmaco, vol.59, issue.11, pp.869-878, 2004.
DOI : 10.1016/j.farmac.2004.06.007

O. Avery, C. Macleod, and M. Mccarty, Studies on the chemical nature of the substance inducing transformation of Pneumococcal types, Resonance, vol.46, issue.9, pp.137-158, 1944.
DOI : 10.1007/s12045-007-0096-0

M. Bally, H. P. Wong, F. Kong, S. Wasan, E. Reimer et al., Biological barriers to cellular delivery of lipid-based DNA carriers, Advanced Drug Delivery Reviews, vol.38, issue.3, pp.291-315, 1999.
DOI : 10.1016/S0169-409X(99)00034-4

M. Beato, M. Truss, and S. Chavez, Control of Transcription by Steroid Hormones, Annals of the New York Academy of Sciences, vol.87, issue.1 Challenges an, pp.93-123, 1996.
DOI : 10.1016/0092-8674(95)90512-X

G. Blume and G. Cevc, Liposomes for the sustained drug release in vivo, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1029, issue.1, pp.91-97, 1990.
DOI : 10.1016/0005-2736(90)90440-Y

D. Bonnet and J. Dick, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nature Medicine, vol.6, issue.7, pp.730-737, 1997.
DOI : 10.1038/367645a0

C. Bosetti, P. Bertuccio, F. Levi, L. Chatenoud, E. Negri et al., The decline in breast cancer mortality in Europe: An update, Breast, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01262966

J. Esteve and J. Faivre, Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM), Eur J Cancer, vol.43, issue.1, pp.149-160, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00434567

O. Boussif, F. Lezoualc-'h, M. Zanta, M. Mergny, D. Scherman et al., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine., Proceedings of the National Academy of Sciences, vol.92, issue.16, pp.92-7297, 1995.
DOI : 10.1073/pnas.92.16.7297

G. Castoria, A. Migliaccio, A. Bilancio, D. Domenico, M. De-falco et al., PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells, The EMBO Journal, vol.20, issue.21, pp.6050-6059, 2001.
DOI : 10.1093/emboj/20.21.6050

D. Chalbos, F. Vignon, I. Keydar, and H. Rochefort, D)*, The Journal of Clinical Endocrinology & Metabolism, vol.55, issue.2, pp.276-283, 1982.
DOI : 10.1210/jcem-55-2-276

K. Chan, I. Espinosa, M. Chao, D. Wong, L. Ailles et al., Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells, Proceedings of the National Academy of Sciences, vol.106, issue.33, pp.14016-14021, 2009.
DOI : 10.1073/pnas.0906549106

E. Chang, J. Frasor, B. Komm, and B. Katzenellenbogen, Impact of Estrogen Receptor ?? on Gene Networks Regulated by Estrogen Receptor ?? in Breast Cancer Cells, Endocrinology, vol.147, issue.10, pp.4831-4842, 2006.
DOI : 10.1210/en.2006-0563

Y. Cho, J. Kim, and K. Park, Polycation gene delivery systems: escape from endosomes to cytosol, Journal of Pharmacy and Pharmacology, vol.96, issue.6, pp.721-734, 2003.
DOI : 10.1211/002235703765951311

S. Choosakoonkriang, B. Lobo, G. Koe, J. Koe, and C. Middaugh, Biophysical Characterization of PEI/DNA Complexes, Journal of Pharmaceutical Sciences, vol.92, issue.8, pp.1710-1722, 2003.
DOI : 10.1002/jps.10437

A. Collins, P. Berry, C. Hyde, M. Stower, and N. Maitland, Prospective Identification of Tumorigenic Prostate Cancer Stem Cells, Cancer Research, vol.65, issue.23, pp.10946-10951, 2005.
DOI : 10.1158/0008-5472.CAN-05-2018

S. Cowley, S. Hoare, S. Mosselman, and M. Parker, Estrogen Receptors ?? and ?? Form Heterodimers on DNA, Journal of Biological Chemistry, vol.272, issue.32, pp.19858-19862, 1997.
DOI : 10.1074/jbc.272.32.19858

M. Curley, V. Therrien, C. Cummings, P. Sergent, C. Koulouris et al., CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer, Stem Cells, vol.27, issue.12, pp.2875-2883, 2009.
DOI : 10.1002/stem.236

D. Rosa, G. , D. Stefano, D. Laguardia, V. Arpicco et al., Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages, Eur J Pharm Biopharm, vol.70, issue.1, pp.7-18, 2008.

X. Gao, K. Kim, and D. Liu, Nonviral gene delivery: What we know and what is next, The AAPS Journal, vol.9, issue.1, pp.92-104, 2007.
DOI : 10.1208/aapsj0901009
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751307

E. Garanger, D. Boturyn, and P. Dumy, Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers, Anti-Cancer Agents in Medicinal Chemistry, vol.7, issue.5, pp.552-558, 2007.
DOI : 10.2174/187152007781668706

H. Gershon, R. Ghirlando, S. Guttman, and A. Minsky, Mode of formation and structural features of DNA-cationic liposome complexes used for transfection, Biochemistry, vol.32, issue.28, pp.7143-7151, 1993.
DOI : 10.1021/bi00079a011

D. Gorlich and U. Kutay, Transport Between the Cell Nucleus and the Cytoplasm, Annual Review of Cell and Developmental Biology, vol.15, issue.1, pp.607-660, 1999.
DOI : 10.1146/annurev.cellbio.15.1.607

M. Gotte and G. Yip, Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective, Cancer Research, vol.66, issue.21, pp.10233-10237, 2006.
DOI : 10.1158/0008-5472.CAN-06-1464

G. Greene, P. Gilna, M. Waterfield, A. Baker, Y. Hort et al., Sequence and expression of human estrogen receptor complementary DNA, Science, vol.231, issue.4742, pp.1150-1154, 1986.
DOI : 10.1126/science.3753802

H. Gronemeyer and V. Laudet, Transcription factors 3: nuclear receptors, Protein Profile, vol.2, issue.11, pp.1173-1308, 1995.

C. Haase, R. Bergmann, J. Oswald, D. Zips, and J. Pietzsch, Neurotensin receptors in adeno-and squamous cell carcinoma, Anticancer Res, vol.26, issue.5A, pp.3527-3533, 2006.

J. Hall and D. Mcdonnell, The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens, Endocrinology, vol.140, issue.12, pp.5566-5578, 1999.

J. Hall and D. Mcdonnell, Coregulators in Nuclear Estrogen Receptor Action: From Concept to Therapeutic Targeting, Molecular Interventions, vol.5, issue.6, pp.343-357, 2005.
DOI : 10.1124/mi.5.6.7

J. Harrell, W. Dye, D. Allred, P. Jedlicka, N. Spoelstra et al., Estrogen Receptor Positive Breast Cancer Metastasis: Altered Hormonal Sensitivity and Tumor Aggressiveness in Lymphatic Vessels and Lymph Nodes, Cancer Research, vol.66, issue.18, pp.9308-9315, 2006.
DOI : 10.1158/0008-5472.CAN-06-1769

J. Hartman, K. Lindberg, A. Morani, J. Inzunza, A. Strom et al., Estrogen Receptor ?? Inhibits Angiogenesis and Growth of T47D Breast Cancer Xenografts, Cancer Research, vol.66, issue.23, pp.11207-11213, 2006.
DOI : 10.1158/0008-5472.CAN-06-0017

H. Hashizume, P. Baluk, S. Morikawa, J. Mclean, G. Thurston et al., Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness, The American Journal of Pathology, vol.156, issue.4, pp.1363-1380, 2000.
DOI : 10.1016/S0002-9440(10)65006-7

N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng et al., Estrogen Receptors: How Do They Signal and What Are Their Targets, Physiological Reviews, vol.87, issue.3, pp.905-931, 2007.
DOI : 10.1152/physrev.00026.2006

H. Hillaireau and P. Couvreur, Nanocarriers??? entry into the cell: relevance to drug delivery, Cellular and Molecular Life Sciences, vol.31, issue.Suppl 1, pp.2873-2896, 2009.
DOI : 10.1007/s00018-009-0053-z

O. Ishida, K. Maruyama, H. Tanahashi, M. Iwatsuru, K. Sasaki et al., Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo, Pharmaceutical Research, vol.18, issue.7, pp.1042-1048, 2001.
DOI : 10.1023/A:1010960900254

A. Ivanov, Exocytosis and endocytosis. Preface, Methods Mol Biol, vol.440, pp.v-vi, 2008.

T. Iversen, T. Skotland, and K. Sandvig, Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies, Nano Today, vol.6, issue.2, pp.176-185, 2011.
DOI : 10.1016/j.nantod.2011.02.003

S. Jaracz, J. Chen, L. Kuznetsova, and I. Ojima, Recent advances in tumor-targeting anticancer drug conjugates, Bioorganic & Medicinal Chemistry, vol.13, issue.17, pp.5043-5054, 2005.
DOI : 10.1016/j.bmc.2005.04.084

B. Jarraya, S. Boulet, G. Ralph, C. Jan, G. Bonvento et al., Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia, Science Translational Medicine, vol.1, issue.2, pp.2-4, 2009.
DOI : 10.1126/scitranslmed.3000130

L. Jin, K. Hope, Q. Zhai, F. Smadja-joffe, and J. Dick, Targeting of CD44 eradicates human acute myeloid leukemic stem cells, Nature Medicine, vol.105, issue.10, pp.1167-1174, 2006.
DOI : 10.1038/nm1483

W. Jiskoot, R. Van-schie, M. Carstens, and H. Schellekens, Immunological Risk of Injectable Drug Delivery Systems, Pharmaceutical Research, vol.17, issue.Suppl 1, pp.1303-1314, 2009.
DOI : 10.1007/s11095-009-9855-9

D. Johnson and C. Walker, CYCLINS AND CELL CYCLE CHECKPOINTS, Annual Review of Pharmacology and Toxicology, vol.39, issue.1, pp.295-312, 1999.
DOI : 10.1146/annurev.pharmtox.39.1.295

C. Kim, E. Jackson, A. Woolfenden, S. Lawrence, I. Babar et al., Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer, Cell, vol.121, issue.6, pp.823-835, 2005.
DOI : 10.1016/j.cell.2005.03.032

K. Kim, Y. Lee, J. Kim, K. Koo, H. Hong et al., Targeted gene therapy of LS174???T human colon carcinoma by anti-TAG-72 immunoliposomes, Cancer Gene Therapy, vol.1, issue.5, pp.331-340, 2008.
DOI : 10.1089/hum.1998.9.14-2083

G. Kuiper, E. Enmark, M. Pelto-huikko, S. Nilsson, and J. Gustafsson, Cloning of a novel receptor expressed in rat prostate and ovary., Proceedings of the National Academy of Sciences, vol.93, issue.12, pp.5925-5930, 1996.
DOI : 10.1073/pnas.93.12.5925

D. Lasic, Liposomes in gene delivery, Boca Raton, 1997.

G. Lazennec, Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis, Cancer Letters, vol.231, issue.2, pp.151-157, 2006.
DOI : 10.1016/j.canlet.2005.01.021
URL : https://hal.archives-ouvertes.fr/inserm-00143901

G. Lazennec, D. Bresson, A. Lucas, C. Chauveau, and F. Vignon, ER beta inhibits proliferation and invasion of breast cancer cells, Endocrinology, vol.142, issue.9, pp.4120-4130, 2001.
URL : https://hal.archives-ouvertes.fr/inserm-00153812

C. Lee, M. Hsiao, Y. Tseng, and F. Chang, Enhanced gene delivery to HER-2-overexpressing breast cancer cells by modified immunolipoplexes conjugated with the anti-HER-2 antibody, Journal of Biomedical Science, vol.1472, issue.3, pp.337-344, 2003.
DOI : 10.1007/BF02256453

J. Legendre, F. Szoka, and J. , Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes, Pharmaceutical Research, vol.09, issue.10, pp.1235-1242, 1992.
DOI : 10.1023/A:1015836829670

E. Leygue, H. Dotzlaw, P. Watson, and L. Murphy, Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis, Cancer Res, vol.58, issue.15, pp.3197-3201, 1998.

C. Li, D. Heidt, P. Dalerba, C. Burant, L. Zhang et al., Identification of Pancreatic Cancer Stem Cells, Cancer Research, vol.67, issue.3, pp.1030-1037, 2007.
DOI : 10.1158/0008-5472.CAN-06-2030

X. Li, M. Lewis, J. Huang, C. Gutierrez, C. Osborne et al., Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy, JNCI Journal of the National Cancer Institute, vol.100, issue.9, pp.672-679, 2008.
DOI : 10.1093/jnci/djn123

M. Lindberg, S. Moverare, S. Skrtic, H. Gao, K. Dahlman-wright et al., Estrogen Receptor (ER)-?? Reduces ER??-Regulated Gene Transcription, Supporting a ???Ying Yang??? Relationship between ER?? and ER?? in Mice, Molecular Endocrinology, vol.17, issue.2, pp.203-208, 2003.
DOI : 10.1210/me.2002-0206

M. Liu, C. Albanese, C. Anderson, K. Hilty, P. Webb et al., Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression, Pestell RG and Kushner PJ J Biol Chem, vol.277, issue.27, pp.24353-24360, 2002.

R. Liu, X. Wang, G. Chen, P. Dalerba, A. Gurney et al., The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells, New England Journal of Medicine, vol.356, issue.3, pp.217-226, 2007.
DOI : 10.1056/NEJMoa063994

D. Lonard, O. Malley, and B. , Nuclear Receptor Coregulators: Judges, Juries, and Executioners of Cellular Regulation, Molecular Cell, vol.27, issue.5, pp.691-700, 2007.
DOI : 10.1016/j.molcel.2007.08.012

C. Managit, S. Kawakami, F. Yamashita, and M. Hashida, Effect of Galactose Density on Asialoglycoprotein Receptor-Mediated Uptake of Galactosylated Liposomes, Journal of Pharmaceutical Sciences, vol.94, issue.10, pp.2266-2275, 2005.
DOI : 10.1002/jps.20443

D. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz et al., The nuclear receptor superfamily: The second decade, Cell, vol.83, issue.6, pp.835-839, 1995.
DOI : 10.1016/0092-8674(95)90199-X

E. Marangoni, N. Lecomte, L. Durand, G. De-pinieux, D. Decaudin et al., CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts, British Journal of Cancer, vol.66, issue.6, pp.918-922, 2009.
DOI : 10.1038/sj.bjc.6604953

B. Martin, M. Sainlos, A. Aissaoui, N. Oudrhiri, M. Hauchecorne et al., The Design of Cationic Lipids for Gene Delivery, Current Pharmaceutical Design, vol.11, issue.3, pp.375-394, 2005.
DOI : 10.2174/1381612053382133

D. Martinez-fong, I. Navarro-quiroga, I. Ochoa, I. Alvarez-maya, M. Meraz et al., Neurotensin-SPDP-poly-l-lysine conjugate: a nonviral vector for targeted gene delivery to neural cells, Molecular Brain Research, vol.69, issue.2, pp.249-262, 1999.
DOI : 10.1016/S0169-328X(99)00114-X

D. Mcdonald and P. Choyke, Imaging of angiogenesis: from microscope to clinic, Nature Medicine, vol.9, issue.6, pp.713-725, 2003.
DOI : 10.1038/nm0603-713

L. Menasce, G. White, C. Harrison, and J. Boyle, Localization of the Estrogen Receptor Locus (ESR) to Chromosome 6q25.1 by FISH and a Simple Post-FISH Banding Technique, Genomics, vol.17, issue.1, pp.263-265, 1993.
DOI : 10.1006/geno.1993.1320

T. Merdan, J. Kopecek, and T. Kissel, Prospects for cationic polymers in gene and oligonucleotide therapy against cancer, Advanced Drug Delivery Reviews, vol.54, issue.5, pp.715-758, 2002.
DOI : 10.1016/S0169-409X(02)00046-7

R. Metivier, G. Penot, M. Hubner, G. Reid, H. Brand et al., Estrogen Receptor-?? Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter, Cell, vol.115, issue.6, pp.751-763, 2003.
DOI : 10.1016/S0092-8674(03)00934-6

S. Mizrahy, S. Raz, M. Hasgaard, H. Liu, N. Soffer-tsur et al., Hyaluronan-coated nanoparticles: The influence of the molecular weight on CD44-hyaluronan interactions and on the immune response, Journal of Controlled Release, vol.156, issue.2, 2011.
DOI : 10.1016/j.jconrel.2011.06.031

S. Mocellin, C. Rossi, L. M. Nitti, and D. , Colorectal cancer vaccines: Principles, results, and perspectives, Gastroenterology, vol.127, issue.6, pp.1821-1837, 2004.
DOI : 10.1053/j.gastro.2004.07.012

J. Moore, D. Mckee, K. Slentz-kesler, L. Moore, S. Jones et al., Cloning and Characterization of Human Estrogen Receptor ?? Isoforms, Biochemical and Biophysical Research Communications, vol.247, issue.1, pp.75-78, 1998.
DOI : 10.1006/bbrc.1998.8738

H. Morrison, L. Sherman, J. Legg, F. Banine, C. Isacke et al., The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44, Genes & Development, vol.15, issue.8, pp.968-980, 2001.
DOI : 10.1101/gad.189601

S. Mosselman, J. Polman, and R. Dijkema, ER??: Identification and characterization of a novel human estrogen receptor, FEBS Letters, vol.10, issue.1, pp.49-53, 1996.
DOI : 10.1016/0014-5793(96)00782-X

L. Murphy and P. Watson, Is oestrogen receptor- ?? a predictor of endocrine therapy responsiveness in human breast cancer?, Endocrine Related Cancer, vol.13, issue.2, pp.327-334, 2006.
DOI : 10.1677/erc.1.01141

T. Nakamura, R. Moriguchi, K. Kogure, A. Minoura, T. Masuda et al., Delivery of Condensed DNA by Liposomal Non-viral Gene Delivery System into Nucleus of Dendritic Cells, Biological & Pharmaceutical Bulletin, vol.29, issue.6, pp.1290-1293, 2006.
DOI : 10.1248/bpb.29.1290

C. Nicolazzi, N. Mignet, N. De-la-figuera, M. Cadet, R. Ibad et al., Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation time, Journal of Controlled Release, vol.88, issue.3, pp.429-443, 2003.
DOI : 10.1016/S0168-3659(03)00067-1
URL : http://dx.doi.org/10.1016/j.ymthe.2004.06.372

P. Noble, Hyaluronan and its catabolic products in tissue injury and repair, Matrix Biology, vol.21, issue.1, pp.25-29, 2002.
DOI : 10.1016/S0945-053X(01)00184-6

O. Brien, C. Pollett, A. Gallinger, S. Dick, and J. , A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, vol.4457123, pp.106-110, 2007.

O. 'lone, R. Frith, M. Karlsson, E. Hansen, and U. , Genomic targets of nuclear estrogen receptors, Mol Endocrinol, vol.18, issue.8, pp.1859-1875, 2004.

V. Orian-rousseau, CD44, a therapeutic target for metastasising tumours, European Journal of Cancer, vol.46, issue.7, pp.1271-1277, 2010.
DOI : 10.1016/j.ejca.2010.02.024

C. Oussoren and G. Storm, Liposomes to target the lymphatics by subcutaneous administration, Advanced Drug Delivery Reviews, vol.50, issue.1-2, pp.143-156, 2001.
DOI : 10.1016/S0169-409X(01)00154-5

C. Palmieri, G. Cheng, S. Saji, M. Zelada-hedman, A. Warri et al., Estrogen receptor beta in breast cancer, Endocrine Related Cancer, vol.9, issue.1, pp.1-13, 2002.
DOI : 10.1677/erc.0.0090001

D. Papahadjopoulos, T. Allen, A. Gabizon, E. Mayhew, K. Matthay et al., Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy., Proceedings of the National Academy of Sciences, vol.88, issue.24, pp.11460-11464, 1991.
DOI : 10.1073/pnas.88.24.11460

R. Pardal, M. Clarke, and S. Morrison, Applying the principles of stem-cell biology to cancer, Nature Reviews Cancer, vol.3, issue.12, pp.895-902, 2003.
DOI : 10.1038/nrc1232

E. Pardue, S. Ibrahim, and A. Ramamurthi, Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering, Organogenesis, vol.80, issue.4, pp.203-214, 2008.
DOI : 10.1016/j.biomaterials.2005.09.035

J. Park, K. Hong, D. Kirpotin, G. Colbern, R. Shalaby et al., Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery, Clin Cancer Res, vol.8, issue.4, pp.1172-1181, 2002.

J. Park, D. Kirpotin, K. Hong, R. Shalaby, Y. Shao et al., Tumor targeting using anti-her2 immunoliposomes, Journal of Controlled Release, vol.74, issue.1-3, pp.1-3, 2001.
DOI : 10.1016/S0168-3659(01)00315-7

T. Skelton, C. Zeng, A. Nocks, and I. Stamenkovic, Glycosylation Provides Both Stimulatory and Inhibitory Effects on Cell Surface and Soluble CD44 Binding to Hyaluronan, The Journal of Cell Biology, vol.250, issue.2, pp.431-446, 1998.
DOI : 10.1002/ijc.2910600404

G. Skliris, K. Munot, S. Bell, P. Carder, S. Lane et al., Reduced expression of oestrogen receptor ? in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model, The Journal of Pathology, vol.98, issue.2, pp.213-220, 2003.
DOI : 10.1002/path.1436

F. Souaze, S. Dupouy, V. Viardot-foucault, E. Bruyneel, S. Attoub et al., Expression of Neurotensin and NT1 Receptor in Human Breast Cancer: A Potential Role in Tumor Progression, Cancer Research, vol.66, issue.12, pp.6243-6249, 2006.
DOI : 10.1158/0008-5472.CAN-06-0450

S. Stephenson, P. Low, and R. Lee, Folate Receptor-Mediated Targeting of Liposomal Drugs to Cancer Cells, Methods Enzymol, vol.387, pp.33-50, 2004.
DOI : 10.1016/S0076-6879(04)87003-4

R. Stern, Devising a pathway for hyaluronan catabolism: are we there yet?, Glycobiology, vol.13, issue.12, pp.105-115, 2003.
DOI : 10.1093/glycob/cwg112
URL : http://glycob.oxfordjournals.org/cgi/content/short/13/12/105R

A. Strom, J. Hartman, J. Foster, S. Kietz, J. Wimalasena et al., Estrogen receptor ?? inhibits 17??-estradiol-stimulated proliferation of the breast cancer cell line T47D, Proceedings of the National Academy of Sciences, vol.101, issue.6, pp.1566-1571, 2004.
DOI : 10.1073/pnas.0308319100

S. Taetz, A. Bochot, C. Surace, S. Arpicco, J. Renoir et al., Hyaluronic Acid-Modified DOTAP/DOPE Liposomes for the Targeted Delivery of Anti-Telomerase siRNA to CD44-Expressing Lung Cancer Cells, Oligonucleotides, vol.19, issue.2, pp.103-116, 2009.
DOI : 10.1089/oli.2008.0168

M. Tang and F. Szoka, The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes, Gene Therapy, vol.4, issue.8, pp.823-832, 1997.
DOI : 10.1038/sj.gt.3300454

D. Tasset, L. Tora, C. Fromental, E. Scheer, and P. Chambon, Distinct classes of transcriptional activating domains function by different mechanisms, Cell, vol.62, issue.6, pp.1177-1187, 1990.
DOI : 10.1016/0092-8674(90)90394-T

C. Thomas, A. Strom, K. Lindberg, and J. Gustafsson, Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling, Breast Cancer Research and Treatment, vol.11, issue.2, pp.417-427, 2011.
DOI : 10.1007/s10549-010-1011-z

D. Tiezzi, F. Valejo, H. Marana, H. Carrara, L. Benevides et al., CD44+/CD24??? cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast, Medical Oncology, vol.10, issue.3, 2011.
DOI : 10.1007/s12032-011-0014-x

B. Toole, Hyaluronan: from extracellular glue to pericellular cue, Nature Reviews Cancer, vol.63, issue.7, pp.528-539, 2004.
DOI : 10.1128/MCB.20.23.8969-8982.2000

N. Toriyabe, Y. Hayashi, M. Hyodo, and H. Harashima, Synthesis and Evaluation of Stearylated Hyaluronic Acid for the Active Delivery of Liposomes to Liver Endothelial Cells, Biological & Pharmaceutical Bulletin, vol.34, issue.7, pp.1084-1089, 2011.
DOI : 10.1248/bpb.34.1084

O. Treeck, C. Lattrich, A. Springwald, and O. Ortmann, Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells, Breast Cancer Research and Treatment, vol.109, issue.2, 2009.
DOI : 10.1007/s10549-009-0413-2
URL : https://hal.archives-ouvertes.fr/hal-00535365

G. Tzircotis, R. Thorne, and C. Isacke, Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding, Journal of Cell Science, vol.118, issue.21, pp.5119-5128, 2005.
DOI : 10.1242/jcs.02629

J. Viallard, F. Lacombe, F. Belloc, J. Pellegrin, and J. Reiffers, M??canismes mol??culaires contr??lant le cycle cellulaire??: aspects fondamentaux et implications en canc??rologie, Cancer/Radioth??rapie, vol.5, issue.2, pp.109-129, 2001.
DOI : 10.1016/S1278-3218(01)00087-7

J. Visvader and G. Lindeman, Cancer stem cells in solid tumours: accumulating evidence and unresolved questions, Nature Reviews Cancer, vol.63, issue.10, pp.755-768, 2008.
DOI : 10.1158/0008-5472.CAN-06-3126

J. Watson and F. Crick, Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid, Nature, vol.9, issue.4356, pp.737-738, 1953.
DOI : 10.1016/0006-3002(53)90232-7

D. West, I. Hampson, F. Arnold, and S. Kumar, Angiogenesis induced by degradation products of hyaluronic acid, Science, vol.228, issue.4705, pp.1324-1326, 1985.
DOI : 10.1126/science.2408340

M. Wicha, S. Liu, and G. Dontu, Cancer Stem Cells: An Old Idea--A Paradigm Shift, Cancer Research, vol.66, issue.4, pp.1883-1890, 2006.
DOI : 10.1158/0008-5472.CAN-05-3153

M. Woodle, K. Matthay, M. Newman, J. Hidayat, L. Collins et al., Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1105, issue.2, pp.193-200, 1992.
DOI : 10.1016/0005-2736(92)90194-Q

L. Xu, C. Huang, W. Huang, W. Tang, A. Rait et al., Systemic tumor-targeted gene delivery by anti-transferrin receptor scFvimmunoliposomes, Mol Cancer Ther, vol.1, issue.5, pp.337-346, 2002.

L. Xu, W. Tang, C. Huang, W. Alexander, L. Xiang et al., Systemic p53 gene therapy of cancer with immunolipoplexes targeted by antitransferrin receptor scFv, Mol Med, vol.7, issue.10, pp.723-734, 2001.

Z. Yang, D. Ho, M. Ng, C. Lau, W. Yu et al., Significance of CD90+ Cancer Stem Cells in Human Liver Cancer, Cancer Cell, vol.13, issue.2, pp.153-166, 2008.
DOI : 10.1016/j.ccr.2008.01.013

N. Chang and R. Boackle, Glycosaminoglycans enhance complement hemolytic efficiency: theoretical considerations for GAG-complement-saliva interactions, Mol Immunol, vol.23, issue.8, pp.887-893, 1986.

R. Deed, P. Rooney, P. Kumar, J. Norton, J. Smith et al., Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan, International Journal of Cancer, vol.183, issue.2, pp.251-256, 1997.
DOI : 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J

R. Diaz-lopez, N. Tsapis, M. Santin, S. Bridal, V. Nicolas et al., The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent, Biomaterials, vol.31, issue.7, pp.1723-1731, 2010.
DOI : 10.1016/j.biomaterials.2009.11.044

J. Grimshaw, J. Trocha-grimshaw, W. Fisher, A. Rice, S. Smith et al., Quantitative analysis of hyaluronan in human synovial fluid using capillary electrophoresis, Electrophoresis, vol.2, issue.2, pp.396-400, 1996.
DOI : 10.1002/elps.1150170218

N. Hooper, Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae (Review), Molecular Membrane Biology, vol.336, issue.2, pp.145-156, 1999.
DOI : 10.1074/jbc.272.31.19242

Y. Liu, D. Liggitt, W. Zhong, G. Tu, K. Gaensler et al., Cationic Liposome-mediated Intravenous Gene Delivery, Journal of Biological Chemistry, vol.270, issue.42, pp.24864-24870, 1995.
DOI : 10.1074/jbc.270.42.24864

M. Long, S. Huang, C. Wu, G. Shackleford, and J. A. , Lipid raft/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells, Journal of Biomedical Science, vol.19, issue.1, p.19, 2012.
DOI : 10.1016/j.tibs.2006.05.006

R. Mahato, K. Kawabata, T. Nomura, Y. Takakura, and M. Hashida, Physicochemical and Pharmacokinetic Characteristics of Plasmici DNA/ Cationic Liposome Complexes, Journal of Pharmaceutical Sciences, vol.84, issue.11, pp.1267-1271, 1995.
DOI : 10.1002/jps.2600841102

P. Noble, Hyaluronan and its catabolic products in tissue injury and repair, Matrix Biology, vol.21, issue.1, pp.25-29, 2002.
DOI : 10.1016/S0945-053X(01)00184-6

D. Peer and M. R. , Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models, International Journal of Cancer, vol.203, issue.5, pp.780-789, 2004.
DOI : 10.1002/ijc.11615

D. Peer and M. R. , Tumor-Targeted Hyaluronan Nanoliposomes Increase the Antitumor Activity of Liposomal Doxorubicin in Syngeneic and Human Xenograft Mouse Tumor Models, Neoplasia, vol.6, issue.4, pp.343-353, 2004.
DOI : 10.1593/neo.03460

C. Plank, K. Mechtler, F. Szoka, J. Wagner, and E. , Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene Delivery, Human Gene Therapy, vol.7, issue.12, pp.1437-1446, 1996.
DOI : 10.1089/hum.1996.7.12-1437

H. Ponta, L. Sherman, and P. Herrlich, CD44: From adhesion molecules to signalling regulators, Nature Reviews Molecular Cell Biology, vol.4, issue.1, pp.33-45, 2003.
DOI : 10.1038/nrm1004

H. Qhattal and X. Liu, Characterization of CD44-Mediated Cancer Cell Uptake and Intracellular Distribution of Hyaluronan-Grafted Liposomes, Molecular Pharmaceutics, vol.8, issue.4, pp.1233-1246, 2011.
DOI : 10.1021/mp2000428

J. Rejman, A. Bragonzi, and M. Conese, Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes, Molecular Therapy, vol.12, issue.3, pp.468-474, 2005.
DOI : 10.1016/j.ymthe.2005.03.038

J. Schnitzer, P. Oh, E. Pinney, and J. Allard, Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules, The Journal of Cell Biology, vol.127, issue.5, pp.1217-1232, 1994.
DOI : 10.1083/jcb.127.5.1217

M. Stewart, G. Plautz, D. Buono, L. Yang, Z. Xu et al., with DNA???Liposome Complexes: Safety and Acute Toxicity in Mice, Human Gene Therapy, vol.3, issue.3, pp.267-275, 1992.
DOI : 10.1089/hum.1992.3.3-267

C. Surace, S. Arpicco, A. Dufay-wojcicki, V. Marsaud, C. Bouclier et al., Lipoplexes Targeting the CD44 Hyaluronic Acid Receptor for Efficient Transfection of Breast Cancer Cells, Molecular Pharmaceutics, vol.6, issue.4, pp.1062-1073, 2009.
DOI : 10.1021/mp800215d

C. Tros-de-ilarduya, Y. Sun, and N. Düzgüne?, Gene delivery by lipoplexes and polyplexes, European Journal of Pharmaceutical Sciences, vol.40, issue.3, pp.159-170, 2010.
DOI : 10.1016/j.ejps.2010.03.019

L. Wang, K. Rothberg, and R. Anderson, Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation, The Journal of Cell Biology, vol.123, issue.5, pp.1107-1117, 1993.
DOI : 10.1083/jcb.123.5.1107

A. Wong, S. Scales, and R. De, DNA Internalized via Caveolae Requires Microtubule-dependent, Rab7-independent Transport to the Late Endocytic Pathway for Delivery to the Nucleus, Journal of Biological Chemistry, vol.282, issue.31, pp.22953-22963, 2007.
DOI : 10.1074/jbc.M611015200

Y. Yang, F. Nunes, K. Berencsi, E. Furth, E. Gonczol et al., Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy., Proceedings of the National Academy of Sciences, vol.91, issue.10, pp.91-4407, 1994.
DOI : 10.1073/pnas.91.10.4407

O. Zelphati, L. Uyechi, L. Barron, F. Szoka, and J. , Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1390, issue.2, pp.119-133, 1998.
DOI : 10.1016/S0005-2760(97)00169-0

N. Zhu, D. Liggitt, Y. Liu, and R. Debs, Systemic gene expression after intravenous DNA delivery into adult mice, Science, vol.261, issue.5118, pp.209-211, 1993.
DOI : 10.1126/science.7687073

I. Bertholon, C. Vauthier, and D. Labarre, Complement Activation by Core???Shell Poly(isobutylcyanoacrylate)???Polysaccharide Nanoparticles: Influences of Surface Morphology, Length, and Type of Polysaccharide, Pharmaceutical Research, vol.17, issue.6, pp.1313-1323, 2006.
DOI : 10.1007/s11095-006-0069-0

G. Dontu, D. El-ashry, and M. Wicha, Breast cancer, stem/progenitor cells and the estrogen receptor, Trends in Endocrinology & Metabolism, vol.15, issue.5, pp.193-197, 2004.
DOI : 10.1016/j.tem.2004.05.011

B. Durst, R. Sorg, G. Roder, B. Betz, M. Beckmann et al., The influence of hormones on CD44 expression in endometrial and breast carcinomas, Oncology Reports, vol.8, issue.5, pp.987-993, 2001.
DOI : 10.3892/or.8.5.987

J. Folkman, Tumor angiogenesis: therapeutic implications, N Engl J Med, vol.285, issue.21, pp.1182-1186, 1971.

J. Folkman, What Is the Evidence That Tumors Are Angiogenesis Dependent?, JNCI Journal of the National Cancer Institute, vol.82, issue.1, pp.4-6, 1990.
DOI : 10.1093/jnci/82.1.4

D. Hicklin and L. Ellis, Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis, Journal of Clinical Oncology, vol.23, issue.5, pp.1011-1027, 2005.
DOI : 10.1200/JCO.2005.06.081

G. Honeth, P. Bendahl, M. Ringner, L. Saal, S. Gruvberger-saal et al., The CD44+/CD24-phenotype is enriched in basal-like breast tumors, Breast Cancer Research, vol.122, issue.3, p.53, 2008.
DOI : 10.1002/ijc.23103

E. Horak, R. Leek, N. Klenk, S. Lejeune, K. Smith et al., Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer, The Lancet, vol.340, issue.8828, pp.1120-1124, 1992.
DOI : 10.1016/0140-6736(92)93150-L

B. Kaipparettu, S. Malik, S. Konduri, W. Liu, M. Rokavec et al., Estrogen-mediated downregulation of CD24 in breast cancer cells, International Journal of Cancer, vol.116, issue.1, pp.66-72, 2008.
DOI : 10.1002/ijc.23480

G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggblad et al., Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta, Endocrinology, vol.138, issue.3, pp.863-870, 1997.

J. Matthews, B. Wihlen, M. Tujague, J. Wan, A. Strom et al., Estrogen Receptor (ER) ?? Modulates ER??-Mediated Transcriptional Activation by Altering the Recruitment of c-Fos and c-Jun to Estrogen-Responsive Promoters, Molecular Endocrinology, vol.20, issue.3, pp.534-543, 2006.
DOI : 10.1210/me.2005-0140

P. Pace, J. Taylor, S. Suntharalingam, R. Coombes, and A. S. , Human Estrogen Receptor ?? Binds DNA in a Manner Similar to and Dimerizes with Estrogen Receptor ??, Journal of Biological Chemistry, vol.272, issue.41, pp.25832-25838, 1997.
DOI : 10.1074/jbc.272.41.25832

K. Pettersson, K. Grandien, G. Kuiper, and J. Gustafsson, Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha, Mol Endocrinol, vol.11, issue.10, pp.1486-1496, 1997.

S. Ricardo, A. Vieira, R. Gerhard, D. Leitao, R. Pinto et al., Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype, Journal of Clinical Pathology, vol.64, issue.11, pp.937-946, 2011.
DOI : 10.1136/jcp.2011.090456

P. Rooney, S. Kumar, J. Ponting, and M. Wang, The role of hyaluronan in tumour neovascularization (review), International Journal of Cancer, vol.183, issue.5, pp.632-636, 1995.
DOI : 10.1002/ijc.2910600511

T. Scholzen and J. Gerdes, The Ki-67 protein: From the known and the unknown, Journal of Cellular Physiology, vol.19, issue.31, pp.311-322, 2000.
DOI : 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9

R. Vartanian and N. Weidner, Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma, Am J Pathol, vol.144, issue.6, pp.1188-1194, 1994.

A. Vonarbourg, C. Passirani, P. Saulnier, and J. Benoit, Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, vol.27, issue.24, pp.4356-4373, 2006.
DOI : 10.1016/j.biomaterials.2006.03.039

D. West, I. Hampson, F. Arnold, and S. Kumar, Angiogenesis induced by degradation products of hyaluronic acid, Science, vol.228, issue.4705, pp.1324-1326, 1985.
DOI : 10.1126/science.2408340

X. Wu, M. Subramaniam, V. Negron, M. Cicek, C. Reynolds et al., Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody, Journal of Cellular Biochemistry, vol.22, issue.(Suppl 1), pp.711-723, 2012.
DOI : 10.1002/jcb.23443

T. Yardeni, M. Eckhaus, H. Morris, M. Huizing, and S. Hoogstraten-miller, Retro-orbital injections in mice, Lab Animal, vol.29, issue.5, pp.155-160, 2011.
DOI : 10.1136/adc.2004.070045

N. Yerushalmi and M. R. , Hyaluronic Acid-Modified Bioadhesive Liposomes as Local Drug Depots: Effects of Cellular and Fluid Dynamics on Liposome Retention at Target Sites, Archives of Biochemistry and Biophysics, vol.349, issue.1, pp.21-26, 1998.
DOI : 10.1006/abbi.1997.0356

J. Felgner, R. Kumar, C. Sridhar, C. Wheeler, Y. Tsai et al., Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations, J Biol Chem, vol.269, issue.4, pp.2550-2561, 1994.

H. Gewurz, S. Mergenhagen, A. Nowotny, and J. Phillips, Interactions of the complement system with native and chemically modified endotoxins, J Bacteriol, vol.95, issue.2, pp.397-405, 1968.

K. Koehler, L. Helguero, L. Haldosen, M. Warner, and J. Gustafsson, Reflections on the Discovery and Significance of Estrogen Receptor ??, Endocrine Reviews, vol.26, issue.3, pp.465-478, 2005.
DOI : 10.1210/er.2004-0027

M. Kucia, R. Reca, K. Miekus, J. Wanzeck, W. Wojakowski et al., Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF-1-CXCR4 Axis, Stem Cells, vol.27, issue.7, pp.879-894, 2005.
DOI : 10.1634/stemcells.2004-0342

F. Liu, A. Frick, X. Yuan, and L. Huang, Dysopsonin Activity of Serum DNA-Binding Proteins Favorable for Gene Delivery, Journal of Pharmacology and Experimental Therapeutics, vol.332, issue.2, pp.500-504, 2010.
DOI : 10.1124/jpet.109.159541

G. Niu, W. Driessen, S. Sullivan, and J. Hughes, In Vivo Anti-Tumor Effect of Expressing p14ARF-TAT Using a FGF2-Targeted Cationic Lipid Vector, Pharmaceutical Research, vol.4, issue.4, pp.720-730, 2011.
DOI : 10.1007/s11095-010-0353-x

T. Reya, S. Morrison, M. Clarke, and I. Weissman, Stem cells, cancer, and cancer stem cells, Nature, vol.414, issue.6859, pp.105-111, 2001.
DOI : 10.1038/35102167

K. Sauve, J. Lepage, M. Sanchez, N. Heveker, and A. Tremblay, Positive Feedback Activation of Estrogen Receptors by the CXCL12-CXCR4 Pathway, Cancer Research, vol.69, issue.14, pp.5793-5800, 2009.
DOI : 10.1158/0008-5472.CAN-08-4924

J. Senior, C. Delgado, D. Fisher, C. Tilcock, and G. Gregoriadis, Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol)-coated vesicles, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1062, issue.1, pp.77-82, 1991.
DOI : 10.1016/0005-2736(91)90337-8

J. Senior, K. Trimble, and R. Maskiewicz, Interaction of positively-charged liposomes with blood: implications for their application in vivo, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1070, issue.1, pp.173-179, 1991.
DOI : 10.1016/0005-2736(91)90160-A

J. Song, J. Im, J. Kang, and D. Kang, A simple method for hyaluronic acid quantification in culture broth, Carbohydrate Polymers, vol.78, issue.3, pp.633-634, 2009.
DOI : 10.1016/j.carbpol.2009.04.033

J. Turek, C. Dubertret, G. Jaslin, K. Antonakis, D. Scherman et al., Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection, The Journal of Gene Medicine, vol.35, issue.1, pp.32-40, 2000.
DOI : 10.1002/(SICI)1521-2254(200001/02)2:1<32::AID-JGM78>3.0.CO;2-U

M. Warner and J. Gustafsson, The role of estrogen receptor ?? (ER??) in malignant diseases???A new potential target for antiproliferative drugs in prevention and treatment of cancer, Biochemical and Biophysical Research Communications, vol.396, issue.1, pp.63-66, 2010.
DOI : 10.1016/j.bbrc.2010.02.144

M. Wicha, S. Liu, and G. Dontu, Cancer Stem Cells: An Old Idea--A Paradigm Shift, Cancer Research, vol.66, issue.4, pp.1883-1890, 2006.
DOI : 10.1158/0008-5472.CAN-05-3153

N. Yew and S. Cheng, Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy, Expert Opinion on Drug Delivery, vol.15, issue.2, pp.115-125, 2004.
DOI : 10.1089/10430340260395910